Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.MedImmune Receives New Order From HHS
MedImmune has revealed that the US Department of Health and Human Services (HHS) has placed an order for an additional 29 million doses of its live attenuated influenza
MedImmune has revealed that the US Department of Health and Human Services (HHS) has placed an order for an additional 29 million doses of its live attenuated influenza
Dalton Pharma Services (Dalton) has expanded its pharmaceutical manufacturing services by adding formulation development to its list of integrated capabilities. Reportedly, Dalton’s analytical, process and formulation scientists are
Praxair China has installed its NCOOL cryogenic heat exchanger system at Shanghai The First Biochemical & Pharmaceutical. The company claims that it is the first liquid nitrogen supply
Forest Laboratories and Glenmark Pharmaceuticals, a subsidiary of Glenmark Pharmaceuticals India (GPL) have announced top-line results from a phase IIb dose range finding study of Oglemilast in patients
Arena Pharmaceuticals has reported positive top-line results from the BLOSSOM (Behavioral modification and LOrcaserin Second Study for Obesity Management) trial. BLOSSOM confirms the results previously reported for the
Buck Systems, part of GEA Pharma has reported that Burkert has successfully built pneumatic-control systems. The system will be used to vibrate pharmaceutical-powder mixing and delivery systems for
Cloud Packaging, a portfolio company of Cameron Holdings, has acquired Toll Packaging Group located in Gibson City, Illinois. Cloud packaging is a provider of a full range of
BioGaia has signed a distribution agreement with the French company, Laboratoires Bioethic. The agreement gives Laboratoires Bioethic exclusive rights to sell BioGaia´s Probiotic drops and tablets in France.
Sanofi-Aventis and Merck have reported that the acquisition by Sanofi-Aventis of Merck’s 50% interest in Merial has been completed. Sanofi-aventis acquired Merck’s interest in Merial for a cash
In addition, should the company satisfy the criteria for initial listing on The NASDAQ Capital Market (except for bid price) as of March 15, 2010, the company will